why choose us

First received: February 09, 2023

Clinical Trial: A Study to Evaluate Safety and Tolerability of a Recombinant Herpes Zoster Vaccine

Study Status: Completed

Recruit Status: RECRUITING

Condition: Herpes Zoster

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-blind, Placebo-controlled Phase I Clinical Study to Evaluate Safety and Tolerability of a Recombinant Herpes Zoster Vaccine (LZ901) in Subjects Aged 50 to 70 Years Inclusive

Brief Summary: This clinical trial is to study the safety and tolerability of a recombinant herpes zoster vaccine (LZ901) and sponsored by Beijing Luzhu Biotechnology Co., Ltd.It is a phase I, randomized, double-blind, placebo-controlled, dose escalation study in healthy people aged 50 to 70 years inclusive.The study is to protect adults against shingles (herpes zoster / varicella zoster virus(VZV)).There will be about 66 participators who will receive two-dose injection at the upper arm.LZ901 vaccine is made up of a…

Read more